Day One Biopharmaceuticals Inc. to Announce Second Quarter 2025 Financial Results

Reuters
22 Jul
<a href="https://laohu8.com/S/DAWN">Day One Biopharmaceuticals Inc.</a> to Announce Second Quarter 2025 Financial Results

Day One Biopharmaceuticals Inc. will report its second quarter 2025 financial results on Tuesday, August 5, 2025. A live conference call and webcast will be hosted at 4:30 p.m. ET, and live audio of the webcast will be accessible on Day One's Events on the Day One Media & Investors page. An archived version of the webcast will be available for replay for 30 days following the event.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Day One Biopharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9497993-en) on July 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10